An Interview with Dr.Chen-Yang Shen , CEO of Taiwan Biobank: Foundation Construction of Future Medical Science
Since ancient times, mankind has been yearning for immortality, as medical science progresses, we can now get a glimpse of the causes of certain diseases through genes for prevention purpose, but some chronic diseases or common diseases require a lot of genetic data to interpret. In consideration of this, many countries have been pursuing on a Biobank program to collect tens of thousands of genetic information for large-scale cross-generational research that will not only improve disease management and prevention strategies but also reduce health care costs. At present, Taiwan is actively establishing a local biobank, and GeneOnline is proud to interview Professor Chen-Yang Shen (沈志陽), the CEO of Taiwan Biobank, to talk about the importance of biobank and the mentality of initiating the project.
It's free! Log in now to read
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02